Document Detail

Is infliximab safe to use while breastfeeding?
MedLine Citation:
PMID:  18494064     Owner:  NLM     Status:  MEDLINE    
Inflammatory bowel disease (IBD) often affects women around the age of conception and pregnancy. Most drugs used to treat IBD are safe in pregnancy, but physicians must consider the clinical implications of certain treatment regimens in young, fertile females. We report an informative case of a pregnant patient with IBD who underwent treatment with infliximab during her pregnancy and while nursing her infant. Serum and breast milk infliximab levels were monitored throughout this time period. This case report suggests that targeted monoclonal antibodies and other biologic agents can be used with caution in pregnant and breastfeeding patients.
Joel-Z Stengel; Hays-L Arnold
Related Documents :
7067574 - Adult acquired antral web.
9458214 - Ankylosing spondylitis--the female aspect.
12743674 - Efficacy, safety and cost of new drugs acting on the central nervous system.
22346034 - Postpartum amaurosis in a woman with severe preeclampsia.
18571094 - Pregnancy-related exacerbation of iatrogenic keratectasia despite corneal collagen cros...
3284364 - The reversal of hydrops fetalis by intravascular intrauterine transfusion in severe iso...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  World journal of gastroenterology : WJG     Volume:  14     ISSN:  1007-9327     ISO Abbreviation:  World J. Gastroenterol.     Publication Date:  2008 May 
Date Detail:
Created Date:  2008-05-21     Completed Date:  2008-08-15     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  100883448     Medline TA:  World J Gastroenterol     Country:  China    
Other Details:
Languages:  eng     Pagination:  3085-7     Citation Subset:  IM    
Gastroenterology Service, Brooke Army Medical Center, Fort Sam Houston, TX 78234, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Inflammatory Agents / adverse effects,  blood,  therapeutic use*
Antibodies, Monoclonal / adverse effects,  therapeutic use*
Breast Feeding*
Crohn Disease / drug therapy*,  metabolism
Gastrointestinal Agents / adverse effects,  blood,  therapeutic use*
Live Birth
Milk, Human / metabolism
Pregnancy Complications / drug therapy*,  metabolism
Risk Assessment
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Antibodies, Monoclonal; 0/Gastrointestinal Agents; 0/infliximab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reoperation of biliary tract by laparoscopy: experiences with 39 cases.
Next Document:  Abscesses of the spleen: report of three cases.